【英文論文

(1)

Publication List-part I

Katsuya Yamamoto (Tokyo Medical and Dental University)

1. Yamamoto K, Nagata K, Morita Y, Inagaki K, Hamaguchi H. Isodicentric Philadel-phia chromosome in acute lymphoblastic leukemia with der(7;12)(q10;q10).

Leukemia Research 31: 713-718, 2007.

2. Yamamoto K, Nagata K, Morita Y, Inagaki K, Hamaguchi H. New complex

t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.

Cancer Genetics and Cytogenetics 137: 119-123, 2002.

3. Yamamoto K, Nagata K, Tsurukubo Y, Inagaki K, Ono R, Taki T, Hayashi Y, Ha-maguchi H. Translocation (8;12)(q13;p13) during disease progression in acute mye-lomonocytic leukemia with t(11;19)(q23;q13.1).

4. Yamamoto K, Nagata K, Kida A, Hamaguchi H. Acquired gain of an X chromosome as the sole abnormality in the blast crisis of chronic neutrophilic leukemia.

5. Yamamoto K, Nagata K, Hamaguchi H. A new case of CD7-positive acute myelo-blastic leukemia with trisomy 21 as a sole acquired abnormality.

6. Yamamoto K, Nagata K, Kida A, Inagaki K, Hamaguchi H. Karyotypic conversion from trisomy 4 to trisomy 14 during the evolution of therapy-related myelodysplas-tic syndrome to acute myeloblasmyelodysplas-tic leukemia.

7. Yamamoto K, Nagata K, Hamaguchi H. Elevated platelet-associated IgG in immune thrombocytopenic purpura associated with Waldenström’s macroglobulinemia.

American Journal of Hematology 69: 84-85, 2002.

8. Yamamoto K, Nagata K, Kida A, Hamaguchi H. Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression.

9. Yamamoto K, Nagata K, Kida A, Tsurukubo Y, Hamaguchi H. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and AML1/ETO rearrangements detected by fluorescence in situ hybridization analysis.

International Journal of Hematology 74: 316-321, 2001.

10. Hamaguchi H, Yamaguchi M, Nagata K, Koike E, Imagunbai M, Tsurukubo Y, Yamamoto, K. Aggressive NK cell lymphoma/leukemia with clonal

der(3)t(1;3)(q12;p25), del(6)(q13) and del(13)(q12q14).

(2)

11. Yamamoto K, Nakamura Y, Arai H, Aoyagi M, Saito K, Furusawa S, Mitani, K. Translocation (14;19)(q32;q13) detected by spectral karyotyping and lack of BCL3 rearrangement in CD5-positive B-cell lymphoma associated with hemophagocytic syndrome.

12. Arai Y, Nakamura Y, Inoue F, Yamamoto K, Saito K, Furusawa S. Glucocorti-coid-induced apoptotic pathways in eosinophils: comparison with glucocorti-coid-sensitive leukemia cells.

13. Saito K, Nakamura Y, Aoyagi M, Waga K, Yamamoto K, Aoyagi A, Inoue F, Naka-mura Y, Arai Y, Tadokoro J, Handa T, Tsurumi S, Arai H, Kawagoe Y, Gunji H, Kitsukawa Y, Takahashi W, Furusawa, S. Low-dose cytarabine and aclarubicin in combination with granulocyte-colony stimulating factor (GAG regimen) for previ-ously treated patients with relapsed or primary resistant acute myelogenous leuke-mia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess of blasts in transformation.

14. Yamamoto K, Nakamura Y, Arai H, Saito K, Furusawa S. Triple Philadelphia chro-mosomes with major-bcr rearrangement in hypotriploid erythroleukaemia.

European Journal of Haematology 65: 182-187, 2000.

15. Yamamoto K, Nakamura Y, Nakamura Y, Saito K, Furusawa,S. Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromo-some-positive chronic myelogenous leukaemia with t(7;11)(p15;p15).

British Journal of Haematology 109: 423-426, 2000.

16. Yamamoto K, Nagata K, Tsurukubo Y, Morishita K, Hamaguchi H. A novel translo-cation t(3;22)(q21;q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombocytosis.

Leukemia Research 24: 453-457, 2000.

17. Yamamoto K, Nagata K, Yagasaki F, Tsurukubo Y, Tamura A, Taniwaki M, Hama-guchi H. Interstitial deletion of the short arm of chromosome 12 during clonal evo-lution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.

18. Katano H, Suda T, Morishita T, Yamamoto K, Hoshino Y, Nakamura K, Tachikawa N, Sata T, Hamaguchi H, Iwamoto A, Mori S. HHV-8-associated solid lymphomas occurring in AIDS patients take anaplastic morphology.

Modern Pathology 13: 77-85, 2000.

19. Hamaguchi H, Nagata K, Yamamoto K, Kobayashi M, Takashima T, Taniwaki M. A new translocation (2;4;12)(p21;q12;p13) in CD7-positive acute myeloid leukemia: a

(3)

variant form of t(4;12).

Cancer Genetics and Cytogenetics114: 427-431, 1999.

20. Saito K, Koizumi K, Goto Y, Yamamoto K, Abe K. Localization of small bowel bleeding by arterial injection of Tc-99m-labeled RBC.

Annals of Nuclear Medicine 13: 191-194, 1999.

21. Yamamoto K, Hamaguchi H, Kobayashi M, Tsurukubo Y, Nagata K. Terminal dele-tion of the long arm of chromosome 9 in acute promyelocytic leukemia with a cryp-tic PML/RARa rearrangement.

22. Yamamoto K, Nagata K, Hamaguchi H. Translocation (11;14)(q13;q32) in CD5-positive B-cell lymphoma associated with haemophagocytic syndrome.

23. Yamamoto K, Hamaguchi H, Nagata K, Hara M, Tone O, Tomita H, Ito, U. Isolated recurrence of granulocytic sarcoma of the brain: successful treatment with surgical resection, intrathecal injection, irradiation and prophylactic systemic chemotherapy.

Japanese Journal of Clinical Oncology 29: 214-218, 1999.

24. Yamamoto K, Hamaguchi H, Nagata K, Shibuya H, Takeuchi H. Splenic irradiation for prolymphocytic leukemia. Is it preferable as an initial treatment or not?

Japanese Journal of Clinical Oncology 28: 267-269, 1998.

25. Yamamoto K, Hamaguchi H, Nagata K, Taniwaki M. A variant Burkitt-type trans-location (8;22)(q24;q11) in multiple myeloma: report of a new case and review of the literature.

26. Yamamoto K, Hamaguchi H, Nagata K, Kobayashi M, Takashima T, Taniwaki M. A new complex translocation (15;20;17)(q22;p13;q21) in acute promyelocytic leuke-mia.

27. Hamaguchi H, Inokuchi K, Nara N, Nagata K, Yamamoto K, Yagasaki F, Dan K. Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodys-plastic syndrome.

28. Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M. Es-tablishment of a novel human myeloid leukaemia cell line (FKH-1) with

t(6;9)(p23;q34) and the expression of dek-can transcript.

(4)

Es-tablishment of a novel human acute myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.

30. Yamamoto K, Hamaguchi H, Nagata K, Kobayashi M, Taniwaki M. Tandem dupli-cation of the MLL gene in myelodysplastic syndrome-derived overt leukemia with trisomy 11.

American Journal of Hematology 55: 41-45, 1997.

31. Yamamoto K, Hamaguchi H, Nagata K, Kobayashi M, Tanimoto F, Taniwaki M. Establishment of a novel human acute myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13 translocations.

Leukemia 11: 599-608. 1997.

32. Tazawa R, Yamamoto K, Suzuki K, Hirokawa K, Hirosawa S, Aoki N. Presence of functional cyclic AMP responsive element in the 3’-untranslated region of the hu-man thrombomodulin gene.

Biochemical and Biophysical Research Communication 200: 1391-1397, 1994.

33. Yamamoto K, Tojo A, Aoki N, Shibuya M. Characterization of the promoter region of the human c-kit proto-oncogene.

Japanese Journal of Cancer Research 84: 1136-1144, 1993.

34. Yamamoto K, Lin HF, Yamashita M, Miyoshi N, Tojo A, Shibuya M. An EcoRI RFLP downstream of the human c-myc gene.

Nucleic Acids Research 24: 6973, 1991.

1. 山本克也 , 長田薫 , 森田百合子 , 浜口裕之 . G-CSF 併用 cytarabine, etoposide 少量持続点滴療法にて寛解導入し得た, 悪性リンパ腫の治療中に発症した治療関連性急性骨髄性白血病. 臨床血液 43: 488-492, 2002. 2. 半田智幸, 山本克也, 田所治朗, 吉川弥須子, 鶴見茂治, 中村裕一, 斉藤憲治, 宇塚善郎, 斉藤淑子, 古澤新平. Hypereosinophilic syndrome の診断から 12 年後に発症した CD19 陽性 acute myeloblastic leukemia.

臨床血液 41: 723-728, 2000.

3. 山本克也, 長田薫, 浜口裕之. Multicentric Castleman’s disease 及び皮膚の anaplastic large cell lymphoma を合併した AIDS の一例.

(5)

4. 山本克也, 長田薫, 浜口裕之. ATRA 投与にて 3 回目の完全寛解を得た後に再発し, 再度 ATRA 投与で 4 回目の寛解に導入し得た APL の一例. 内科 82: 382-384, 1998. 5. 山本克也, 長田薫, 浜口裕之. Busulfan 投与による高度骨髄低形成から回復後, 完全寛解を維持している本態性血小板血症の一例. 癌と化学療法 24: 365-369, 1997. 6. 藤川いずみ, 鄭東姫, 矢ケ崎史治, 山本克也, 長田薫, 浜口裕之, 三宅祥三. 病初期に単球増加を伴い, VEPA 療法中に間質性肺炎を合併した angiotropic lymphoma の一剖検例. 日本内科学会雑誌 85: 271-273, 1996. 7. 山本克也, 広沢信作. 慢性骨髄性白血病と BCR-ABL 蛋白質. 医学のあゆみ 169: 297-301, 1994.

8. 山本克也, 渋谷正史. Dr. Dejean, Dr. Evans らの t(15;17)APL における PML-RAR遺伝子の研究.

Oncologia 25: 225-227, 1992.

9. 山本克也, 東條有伸. c-kit レセプターおよびそのリガンド(SCF)と造血. 医学のあゆみ 158: 317-322, 1991.

10. 山本克也, 安東治彦, 西成田真, 平井信二, 中村裕一, 長山礼三, 森

川聡, 高橋敦. アルコール性肝硬変に合併した spur cell anemia の一例. 日立医学会雑誌 57: 56-61, 1990. 11. 山本克也, 東田修二, 三木徹, 鈴木利哉, 長田薫, 神山尚, 三浦修, 今井康文, 村上直己, 加藤淳, 奈良信雄, 青木延雄. 原発性マクログロブリン血症の経過中に急性骨髄性白血病と肝細胞癌を合併した一例. 臨床血液 31: 984-988, 1990. 12. 山本克也, 窪田哲朗, 上坂等, 立石睦人, 奥田正治. CT が診断の一助となった副腎結核の一例. 日立医学会雑誌 55: 6-7, 1989.